RE:RE:The $1.69 conversion price is concerning I am speading unbiased opinions, not fear.
Are you ignoring $32M loss on the sun pharma side. The company is keeping cutting amazing deals for the bankers not shareholders. The $1.69 conversion price is brutal.
Also, they do need another $100M financing. Check their materials.
The price reaction today has proven that it will be a long way for the company to be on track. Given that more and more shares are coming to the market, the selling pressure will be always there, thereby keeping the price down for a long period of time.